NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

LP set the precedent of stating at which large conferences they would not share TLD ( she thought it was “important” to do that). The first one was ASCO 2021. She has not done this for SNO 2021. If she wants to avoid “soul killing,” as you put it, she’d simply let people know no TLD surprises at SNO 2021. Maybe she does not know one way or the other yet.

Look, journals aren’t totally unselfish. They want any pre-journal release, if there is one, at a conference, to be bare bones. If the TLD is last but not least to be accepted at SNO, as an LBA, it could be followed on Sunday evening or Monday evening by a journal article(s). The release at a conference would obviously help prime peer discourse, followed by a comprehensive journal publication(s).

If it’s not going to be SNO, LP could do like she did at the ASM (re: no ASCO), and say no SNO 2021, but publication appears close. So far she has chosen not to do that.